PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION
Provided herein are proteins that include different combinations of structural and nonstructural proteins from SARS-CoV-2 and MERS-CoV. Also provided are polynucleotides encoding the proteins of the present disclosure. In one embodiment, a polynucleotide encoding a protein is present as a viral vect...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROTHE, Eric PATEL, Snehal CHOPRA, Ashok K SHA, Jian |
| description | Provided herein are proteins that include different combinations of structural and nonstructural proteins from SARS-CoV-2 and MERS-CoV. Also provided are polynucleotides encoding the proteins of the present disclosure. In one embodiment, a polynucleotide encoding a protein is present as a viral vector, such as adenovirus. In one embodiment, a polynucleotide encoding a protein is present as a mRNA. Also provided are methods for using the proteins and polynucleotides of the present disclosure.
L'invention concerne des protéines qui comprennent différentes combinaisons de protéines structurales et non structurales provenant du SARS-CoV-2 et du MERS-CoV. L'invention concerne en outre des polynucléotides codant pour les protéines de la présente invention. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un vecteur viral, tel qu'un adénovirus. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un ARNm. L'invention divulgue également des méthodes d'utilisation des protéines et des polynucléotides de la présente divulgation. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022035962A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022035962A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022035962A23</originalsourceid><addsrcrecordid>eNrjZPAMCPIPcfX0C9ZRCPD3ifQLdfZx9Q_xdHEFCjj6uSj4uoZ4-LsEK7j5BymEBLk6hnj6uSs4-wf5-zmGeQaFBit4-rm5Ood4-vvxMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAyMjA2NTSzMjRyNj4lQBABv0LnU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION</title><source>esp@cenet</source><creator>ROTHE, Eric ; PATEL, Snehal ; CHOPRA, Ashok K ; SHA, Jian</creator><creatorcontrib>ROTHE, Eric ; PATEL, Snehal ; CHOPRA, Ashok K ; SHA, Jian</creatorcontrib><description>Provided herein are proteins that include different combinations of structural and nonstructural proteins from SARS-CoV-2 and MERS-CoV. Also provided are polynucleotides encoding the proteins of the present disclosure. In one embodiment, a polynucleotide encoding a protein is present as a viral vector, such as adenovirus. In one embodiment, a polynucleotide encoding a protein is present as a mRNA. Also provided are methods for using the proteins and polynucleotides of the present disclosure.
L'invention concerne des protéines qui comprennent différentes combinaisons de protéines structurales et non structurales provenant du SARS-CoV-2 et du MERS-CoV. L'invention concerne en outre des polynucléotides codant pour les protéines de la présente invention. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un vecteur viral, tel qu'un adénovirus. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un ARNm. L'invention divulgue également des méthodes d'utilisation des protéines et des polynucléotides de la présente divulgation.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220217&DB=EPODOC&CC=WO&NR=2022035962A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220217&DB=EPODOC&CC=WO&NR=2022035962A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROTHE, Eric</creatorcontrib><creatorcontrib>PATEL, Snehal</creatorcontrib><creatorcontrib>CHOPRA, Ashok K</creatorcontrib><creatorcontrib>SHA, Jian</creatorcontrib><title>PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION</title><description>Provided herein are proteins that include different combinations of structural and nonstructural proteins from SARS-CoV-2 and MERS-CoV. Also provided are polynucleotides encoding the proteins of the present disclosure. In one embodiment, a polynucleotide encoding a protein is present as a viral vector, such as adenovirus. In one embodiment, a polynucleotide encoding a protein is present as a mRNA. Also provided are methods for using the proteins and polynucleotides of the present disclosure.
L'invention concerne des protéines qui comprennent différentes combinaisons de protéines structurales et non structurales provenant du SARS-CoV-2 et du MERS-CoV. L'invention concerne en outre des polynucléotides codant pour les protéines de la présente invention. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un vecteur viral, tel qu'un adénovirus. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un ARNm. L'invention divulgue également des méthodes d'utilisation des protéines et des polynucléotides de la présente divulgation.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAMCPIPcfX0C9ZRCPD3ifQLdfZx9Q_xdHEFCjj6uSj4uoZ4-LsEK7j5BymEBLk6hnj6uSs4-wf5-zmGeQaFBit4-rm5Ood4-vvxMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAyMjA2NTSzMjRyNj4lQBABv0LnU</recordid><startdate>20220217</startdate><enddate>20220217</enddate><creator>ROTHE, Eric</creator><creator>PATEL, Snehal</creator><creator>CHOPRA, Ashok K</creator><creator>SHA, Jian</creator><scope>EVB</scope></search><sort><creationdate>20220217</creationdate><title>PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION</title><author>ROTHE, Eric ; PATEL, Snehal ; CHOPRA, Ashok K ; SHA, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022035962A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ROTHE, Eric</creatorcontrib><creatorcontrib>PATEL, Snehal</creatorcontrib><creatorcontrib>CHOPRA, Ashok K</creatorcontrib><creatorcontrib>SHA, Jian</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROTHE, Eric</au><au>PATEL, Snehal</au><au>CHOPRA, Ashok K</au><au>SHA, Jian</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION</title><date>2022-02-17</date><risdate>2022</risdate><abstract>Provided herein are proteins that include different combinations of structural and nonstructural proteins from SARS-CoV-2 and MERS-CoV. Also provided are polynucleotides encoding the proteins of the present disclosure. In one embodiment, a polynucleotide encoding a protein is present as a viral vector, such as adenovirus. In one embodiment, a polynucleotide encoding a protein is present as a mRNA. Also provided are methods for using the proteins and polynucleotides of the present disclosure.
L'invention concerne des protéines qui comprennent différentes combinaisons de protéines structurales et non structurales provenant du SARS-CoV-2 et du MERS-CoV. L'invention concerne en outre des polynucléotides codant pour les protéines de la présente invention. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un vecteur viral, tel qu'un adénovirus. Dans un mode de réalisation, un polynucléotide codant pour une protéine est présent sous la forme d'un ARNm. L'invention divulgue également des méthodes d'utilisation des protéines et des polynucléotides de la présente divulgation.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022035962A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROTHE,%20Eric&rft.date=2022-02-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022035962A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |